Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 27;12(5):e8320.
doi: 10.7759/cureus.8320.

Telogen Effluvium: A Review of the Literature

Affiliations
Review

Telogen Effluvium: A Review of the Literature

Fahham Asghar et al. Cureus. .

Abstract

Telogen effluvium is one of the most common causes of alopecia. It is a scalp disorder characterized by excessive shedding of hair. Several factors such as drugs, trauma, and emotional and physiological stress can lead to the development of telogen effluvium. Multiple alterations in the hair cycle have been proposed as the underlying mechanism. Telogen effluvium can present as acute or chronic hair fall with symptoms such as trichodynia. Diagnostic tests that can be used include hair wash test, trichogram, phototrichogram, and scalp biopsy. In the treatment of telogen effluvium, it is essential to identify and remove the causative factors and to use drugs such as corticosteroids, minoxidil, and novel treatments such as CNPDA (caffeine, niacinamide, panthenol, dimethicone, and an acrylate polymer). Herein, we discuss the presentation, diagnostic approaches, and effective treatment options available for telogen effluvium.

Keywords: acute telogen effluvium; alopecia; causes of telogen effluvium; chronic telogen effluvium; diagnosis; epidemiology; literature review; pathogenesis; telogen effluvium; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Telogen efflfluvium. Grover C, Khurana A. Indian J Dermatol Venereol Leprol. 2013;79:591–603. - PubMed
    1. Telogen effluvium: new concepts and review. Headington JT. Arch Dermatol. 1993;129:356–363. - PubMed
    1. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. Whiting DA. J Am Acad Dermatol. 1996;35:899–906. - PubMed
    1. Drug reactions affecting hair: diagnosis. Tosti A, Pazzaglia M. Dermatol Clin. 2007;25:223–231. - PubMed
    1. Telogen effluvium. Harrison S, Sinclair R. Clin Exp Dermatol. 2002;27:389–395. - PubMed

LinkOut - more resources